Testosterone Without Labs: The Clinical Malpractice No One Talks About

The Standard of Care Problem

Testosterone replacement therapy (TRT) has become one of the most prescribed treatments in modern medicine—and one of the most prescribed without adequate diagnostic workup. This isn't a gray area. The American Urological Association, American Academy of Clinical Endocrinologists, and Endocrine Society all specify the same baseline requirement: confirm symptomatic hypogonadism with two separate serum testosterone measurements before initiating therapy.

Yet a growing body of evidence suggests this recommendation is routinely ignored. Patients are handed prescriptions based on a single lab draw, a symptom checklist, or—in some cases—no labs at all.

As a physician, I need to be direct: this is malpractice territory.

Why Baseline Testing Matters (Beyond Compliance)

1. You Need Two Separate Testosterone Measurements

Testosterone is not static. Circadian variation, stress, sleep quality, and metabolic state all influence a single draw. Morning levels can be 15–25% higher than afternoon levels. A man with a 480 ng/dL morning test may show 350 ng/dL at 2 PM.

The standard recommendation—testing on two separate mornings, ideally within 1–2 weeks—exists because a single measurement can misclassify a patient as hypogonadal when his actual baseline is borderline or normal.

2. You Must Rule Out Secondary Causes

Low testosterone is a symptom, not a diagnosis. Before TRT, you need:

• LH and FSH (to distinguish primary vs. secondary hypogonadism)
• Prolactin (elevated prolactin suppresses GnRH, tanking testosterone)
• TSH, free T4 (thyroid dysfunction drives hypogonadism)
• Fasting glucose and HbA1c (metabolic dysfunction and insulin resistance suppress testosterone)
• Cortisol and ACTH (chronic cortisol elevation suppresses GnRH and LH)
• Liver function tests (albumin, total protein—testosterone binds to SHBG, which is synthesized in the liver)
• Estradiol (especially in men with obesity or liver disease; elevated estradiol suppresses LH feedback and accelerates aromatization of exogenous testosterone)

If a man has low testosterone because of uncontrolled diabetes, sleep apnea, or primary hypothyroidism, TRT alone will not fix the problem—and may worsen it by delaying treatment of the root cause.

3. Baseline Labs Predict Response and Risk

A man with a baseline LH of 2 mIU/mL and total testosterone of 250 ng/dL will respond differently to TRT than a man with LH of 0.5 mIU/mL and total testosterone of 300 ng/dL. The first has some residual endocrine function; the second may have secondary hypogonadism from pituitary suppression or hypothalamic dysfunction.

Baseline estradiol, hematocrit, and lipid profile also predict individual risk for::

• Polycythemia (elevated hematocrit on TRT)
• Lipid deterioration (TRT can lower HDL and raise triglycerides, especially in men with metabolic syndrome)
• Aromatization sensitivity (men with elevated baseline estradiol or high body fat often require aromatase inhibitor co-therapy)

What Every Patient Should Have Before Starting TRT

Mandatory baseline panel:

• Total testosterone (two measurements, both AM)
• Free testosterone (calculated or direct)
• LH, FSH
• Prolactin
• TSH, free T4
• Estradiol (sensitive assay)
• DHT (optional but useful)
• Fasting glucose, HbA1c
• Lipid panel (total cholesterol, LDL, HDL, triglycerides)
• Hematocrit, hemoglobin
• Liver function tests (AST, ALT, albumin)
• Creatinine, BUN (renal function)
• PSA (baseline, especially if age >50)
• Blood pressure

Optional but recommended:

• Morning cortisol and ACTH (if fatigue, depression, or metabolic dysfunction present)
• Thyroid antibodies (TPO, TgAb) if autoimmune risk
• Sleep study (if daytime somnolence, loud snoring, or witnessed apneas)

The Synergy Problem: TRT and Supplementation

Many men self-prescribe supplements before getting baseline labs, which further obscures diagnosis. Consider:

• Zinc and magnesium glycinate both increase testosterone synthesis and can lower SHBG, increasing free testosterone. Without knowing baseline free testosterone, you can't distinguish supplementation-driven change from endogenous dysfunction.
• Ashwagandha and berberine both reduce cortisol and improve insulin sensitivity—but if a man's low testosterone is secondary to uncontrolled hyperglycemia, supplements alone might mask the diabetes problem.
• Creatine increases DHT conversion, which is amplified once exogenous testosterone is added. Baseline DHT is essential.
• NAC and vitamin D3 both support testosterone synthesis, but vitamin D3 also suppresses parathyroid hormone and influences calcium metabolism. Baseline vitamin D and calcium are critical before adding both supplementation and TRT.

Without baseline labs, you cannot determine whether supplements are therapeutic or driving unintended endocrine consequences.

Bottom Line

Testosterone replacement is a legitimate therapy for symptomatic hypogonadism—but only after confirming the diagnosis and ruling out reversible secondary causes. Any provider prescribing TRT without:

1. Two separate testosterone measurements
2. LH, FSH, prolactin, estradiol
3. Thyroid, metabolic, and liver function panels
4. Baseline hematocrit and PSA

...is practicing below the standard of care, period. Demand your labs. Read them. Understand what they mean. And if a provider resists—find another provider.

Disclaimer: This content is for educational purposes only and does not constitute medical advice.